Evidence map›Paper›PMID 40459022›Full record

ArticleMolecular imaging and radionuclide therapy2025

The Poor Prognostic Stigma of Hepatic Superscan on

Dhuha Al-Adhami, Malik Juweid, Akram Al-Ibraheem

Abstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dhuha Al-AdhamiKing Hussein Cancer Center (KHCC), Department of Nuclear Medicine and PET/CT, Al-Jubeiha, Amman, Jordan.ORCID 0000-0002-6913-677X
Malik JuweidUniversity of Jordan, Department of Radiology and Nuclear Medicine, Division of Nuclear Medicine, Amman, Jordan.ORCID 0000-0002-6294-8118
Akram Al-IbraheemKing Hussein Cancer Center (KHCC), Department of Nuclear Medicine and PET/CT, Al-Jubeiha, Amman, Jordan.ORCID 0000-0002-0978-4716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic exocrine carcinoma (PEC) is a lethal malignancy with high mortality rates because of its aggressive nature and frequent late-stage diagnosis. When histopathological diagnosis becomes unfeasible because of patient deterioration, clinicians must rely on clinical, biochemical, and radiological findings. This case report describes a 78-year-old woman with aggressive PEC visualized through

Indexed as

18F-FDGfulminant metastasishepatic superscanPancreatic carcinomaPET/CT

Identifiers

PMID40459022
PMCPMC12134963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.